Posted on Leave a comment

Global Autoimmune Diseases Drugs Market to Grow at a CAGR of 5.57% to 2020

“Global Autoimmune Drugs Market 2016-2020”

Global Autoimmune Diseases Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The report covers the present scenario and the growth prospects of the global autoimmune diseases drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of autoimmune diseases.

Autoimmune diseases are immunological disorders that occur when the immune system attacks and destroys healthy tissues in the body rather than foreign bodies, causing significant pain, inflammation, and organ damage. These diseases can affect the nervous system, cardiovascular system, and musculoskeletal system or individual organs, including the skin, lungs, kidneys, glands, and joints.

Complete Report Available at:

Autoimmune diseases occur due to genetic, infectious, or environmental factors. There are over 80 autoimmune diseases, including AS, IBD (CD and UC), MS, RA, SLE, and PsA. DMARDs, NSAIDs, corticosteroids, analgesics, and immunosuppressants are the major drug classes used to treat autoimmune diseases. The market is divided into Americas, APAC, and EMEA based on geography. Promising pipeline is considered as market driver whereas Loss of patent exclusivity of branded therapies come up as market challenge.

Key questions answered in this report:

– What will the market size be in 2020 and what will the growth rate be?

– What are the key market trends?

– What is driving this market?

– What are the challenges to market growth?

– Who are the Key vendors in this market space?

– What are the market opportunities and threats faced by the key vendors?

– What are the strengths and weaknesses of the key vendors?

Purchase this Report at:

Table of Content:

01: Executive summary

02: Scope of the report

03: Market research methodology

04: Introduction

05: Disease overview

06: Pipeline portfolio

07: Market landscape

08: Market segmentation by type of disease

09: Market segmentation by mechanism of action

10: Market segmentation by drug class

11: Market segmentation by type of molecule

12: Market segmentation by ROA

13: Market segmentation by dosage form

14: Geographical segmentation

15: Market drivers

16: Impact of drivers

17: Market challenges

18: Impact of drivers and challenges

19: Market trends

20: Vendor landscape

21: Appendix

22: Explore Publisher

Get Sample Report at:

Media Contact
Company Name: ReportsWeb
Contact Person: Rajat Sahni
Phone: +1-646-491-9876
Country: United States